Literature DB >> 26738864

miR-488 acts as a tumor suppressor gene in gastric cancer.

Yan Zhao1, Guifang Lu1, Xiquan Ke1, Xinlan Lu1, Xin Wang1, Hongxia Li1, Mudan Ren2, Shuixiang He3.   

Abstract

MicroRNAs (miRNAs) are small, non-coding RNAs that modulate development, cell proliferation, and apoptosis. The deregulated expression of microRNAs is found in carcinogenesis including gastric cancer (GC). In this study, we showed that the expression levels of miR-488 were downregulated in GC tissues compared to in non-tumor tissues. In addition, the expression of miR-488 was also lower in GC cell lines in contrast with the gastric epithelial cell line (GES). In addition, the expression level of miR-488 was negatively correlated with the TNM stage in GC patients, and lower miR-488 expression was found in tumors with advanced TNM stage. The ectopic expression of miR-488 suppressed the GC cell proliferation, cell cycle, colony information, and migration. PAX6 was identified as a direct target gene of miR-488 in HGC-27. Moreover, we found that the expression level of PAX6 was upregulated in the GC tissues compared with the non-tumor tissues. The PAX6 expression level was correlated with the cancer TNM stage, and higher PAX6 expression was found in tumors with advanced TNM stage. Furthermore, there was an inverse correlation between PAX6 and miR-488 expression levels in GC tissues. Therefore, these studies demonstrated that miR-488 might act as a tumor suppressor miRNA in the development of GC.

Entities:  

Keywords:  Gastric cancer; PAX6; miR-488; microRNA

Mesh:

Substances:

Year:  2016        PMID: 26738864     DOI: 10.1007/s13277-015-4645-y

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  50 in total

1.  MicroRNA-148a is silenced by hypermethylation and interacts with DNA methyltransferase 1 in gastric cancer.

Authors:  Akao Zhu; Jiazeng Xia; Junbo Zuo; Shimao Jin; Hong Zhou; Lubin Yao; Hongyu Huang; Zhijun Han
Journal:  Med Oncol       Date:  2011-12-14       Impact factor: 3.064

2.  PAX6 expression may be protective against dopaminergic cell loss in Parkinson's disease.

Authors:  Meghan G Thomas; Caitlyn Welch; Leah Stone; Peter Allan; Roger A Barker; Robert B White
Journal:  CNS Neurol Disord Drug Targets       Date:  2016       Impact factor: 4.388

3.  miR-99a directly targets the mTOR signalling pathway in breast cancer side population cells.

Authors:  Z Yang; Y Han; K Cheng; G Zhang; X Wang
Journal:  Cell Prolif       Date:  2014-10-27       Impact factor: 6.831

Review 4.  MicroRNAs as potential biomarkers for gastric cancer.

Authors:  Han-Shao Liu; Hua-Sheng Xiao
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

Review 5.  MicroRNAs predict and modulate responses to chemotherapy in colorectal cancer.

Authors:  Xin Yu; Zheng Li; Jun Yu; Matthew T V Chan; William K K Wu
Journal:  Cell Prolif       Date:  2015-07-22       Impact factor: 6.831

Review 6.  MicroRNA dysregulation in rhabdomyosarcoma: a new player enters the game.

Authors:  Zheng Li; Xin Yu; Jianxiong Shen; Yang Liu; Matthew T V Chan; William K K Wu
Journal:  Cell Prolif       Date:  2015-07-23       Impact factor: 6.831

7.  Expression profile of microRNAs in gastrointestinal stromal tumors revealed by high throughput quantitative RT-PCR microarray.

Authors:  Han-Xing Tong; Yu-Hong Zhou; Ying-Yong Hou; Yong Zhang; Yuan Huang; Bin Xie; Jiong-Yuan Wang; Quan Jiang; Jun-Yi He; Ye-Bo Shao; Wu-Mei Han; Ruo-Ying Tan; Jun Zhu; Wei-Qi Lu
Journal:  World J Gastroenterol       Date:  2015-05-21       Impact factor: 5.742

8.  Identification of novel caspase/autophagy-related gene switch to cell fate decisions in breast cancers.

Authors:  L-L Fu; Y Yang; H-L Xu; Y Cheng; X Wen; L Ouyang; J-K Bao; Y-Q Wei; B Liu
Journal:  Cell Prolif       Date:  2013-01-04       Impact factor: 6.831

9.  Integrative analysis of miRNA and mRNA expression profiles in pheochromocytoma and paraganglioma identifies genotype-specific markers and potentially regulated pathways.

Authors:  Aguirre A de Cubas; L Javier Leandro-García; Francesca Schiavi; Veronika Mancikova; Iñaki Comino-Méndez; Lucía Inglada-Pérez; Manuel Perez-Martinez; Nuria Ibarz; Pilar Ximénez-Embún; Elena López-Jiménez; Agnieszka Maliszewska; Rocío Letón; Alvaro Gómez Graña; Carmen Bernal; Cristina Alvarez-Escolá; Cristina Rodríguez-Antona; Giuseppe Opocher; Javier Muñoz; Diego Megias; Alberto Cascón; Mercedes Robledo
Journal:  Endocr Relat Cancer       Date:  2013-06-24       Impact factor: 5.678

10.  Regulation of cerebral cortical neurogenesis by the Pax6 transcription factor.

Authors:  Martine N Manuel; Da Mi; John O Mason; David J Price
Journal:  Front Cell Neurosci       Date:  2015-03-10       Impact factor: 5.505

View more
  18 in total

1.  MiR-488 suppresses cell proliferation and invasion by targeting ADAM9 and lncRNA HULC in hepatocellular carcinoma.

Authors:  Dengdi Hu; Dan Shen; Min Zhang; Nengmeng Jiang; Feng Sun; Shibo Yuan; Kaiming Wan
Journal:  Am J Cancer Res       Date:  2017-10-01       Impact factor: 6.166

2.  Association of Androgenic Regulation and MicroRNAs in Acinar Adenocarcinoma of Prostate.

Authors:  Julio Guilherme Balieiro Bernardes; Marianne Rodrigues Fernandes; Juliana Carla Gomes Rodrigues; Lui Wallacy Morikawa Souza Vinagre; Lucas Favacho Pastana; Elizabeth Ayres Fragoso Dobbin; Jéssyca Amanda Gomes Medeiros; Leonidas Braga Dias Junior; Gabriel Monteiro Bernardes; Izabel Maria Monteiro Bernardes; Ney Pereira Carneiro Dos Santos; Samia Demachki; Rommel Mario Rodriguez Burbano
Journal:  Genes (Basel)       Date:  2022-03-30       Impact factor: 4.141

3.  microRNA‑372 inhibits proliferation and induces apoptosis in human breast cancer cells by directly targeting E2F1.

Authors:  Ya-Xin Zhao; Hua-Cheng Liu; Wei-Yang Ying; Cheng-Yu Wang; Yao-Jun Yu; Wei-Jian Sun; Jie-Fan Liu
Journal:  Mol Med Rep       Date:  2017-09-22       Impact factor: 2.952

4.  Overexpression of Transforming Acidic Coiled Coil‑Containing Protein 3 Reflects Malignant Characteristics and Poor Prognosis of Glioma.

Authors:  Ying Sun; Yu Tian; Guang-Zhi Wang; Shi-Hong Zhao; Bo Han; Yong-Li Li; Chuan-Lu Jiang
Journal:  Int J Mol Sci       Date:  2017-03-04       Impact factor: 5.923

5.  MiR-488 inhibits proliferation and cisplatin sensibility in non-small-cell lung cancer (NSCLC) cells by activating the eIF3a-mediated NER signaling pathway.

Authors:  Chao Fang; Yi-Xin Chen; Na-Yiyuan Wu; Ji-Ye Yin; Xiang-Ping Li; Hsuan-Shun Huang; Wei Zhang; Hong-Hao Zhou; Zhao-Qian Liu
Journal:  Sci Rep       Date:  2017-01-11       Impact factor: 4.379

6.  microRNA-488 inhibits chemoresistance of ovarian cancer cells by targeting Six1 and mitochondrial function.

Authors:  Zhuo Yang; ZiYi Feng; JiaHui Gu; XinHui Li; QianZhe Dong; KuiRan Liu; Yan Li; Ling OuYang
Journal:  Oncotarget       Date:  2017-09-15

7.  Generation of a PAX6 knockout glioblastoma cell line with changes in cell cycle distribution and sensitivity to oxidative stress.

Authors:  Beate Hegge; Eva Sjøttem; Ingvild Mikkola
Journal:  BMC Cancer       Date:  2018-05-02       Impact factor: 4.430

8.  MicroRNA-488 inhibits proliferation, invasion and EMT in osteosarcoma cell lines by targeting aquaporin 3.

Authors:  Jing Qiu; Yongzhi Zhang; Hu Chen; Zhi Guo
Journal:  Int J Oncol       Date:  2018-07-16       Impact factor: 5.650

9.  miR-488 inhibits cell growth and metastasis in renal cell carcinoma by targeting HMGN5.

Authors:  Xin Wei; Lili Yu; Xiangbo Kong
Journal:  Onco Targets Ther       Date:  2018-04-18       Impact factor: 4.147

10.  Histone demethylase PHF8 accelerates the progression of colorectal cancer and can be regulated by miR-488 in vitro.

Authors:  Yao Lv; Yan Shi; Quanli Han; Guanghai Dai
Journal:  Mol Med Rep       Date:  2017-08-01       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.